Rupert L. Beale

Gower Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.

High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.

Journal: PloS one

Published: October 21, 2025

Impact of First SARS-CoV-2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study.

Impact of First SARS-CoV-2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study.

Journal: Influenza and other respiratory viruses

Published: July 18, 2025

Autophagy machinery as exploited by viruses.

Autophagy machinery as exploited by viruses.

Journal: Autophagy reports

Published: April 09, 2025

Conjugation of ATG8s to single membranes at a glance.

Conjugation of ATG8s to single membranes at a glance.

Journal: Journal of cell science

Published: August 15, 2024

Caspase cleavage of influenza A virus M2 disrupts M2-LC3 interaction and regulates virion production.

Caspase cleavage of influenza A virus M2 disrupts M2-LC3 interaction and regulates virion production.

Journal: EMBO reports

Published: July 02, 2024

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Journal: The Lancet. Infectious diseases

Published: April 11, 2024

The V-ATPase/ATG16L1 axis is controlled by the V1H subunit.

The V-ATPase/ATG16L1 axis is controlled by the V1H subunit.

Journal: Molecular cell

Published: December 18, 2023

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Journal: The Lancet. Rheumatology

Published: November 16, 2023

CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.

CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.

Journal: mBio

Published: September 01, 2023

SARS-CoV-2 mucosal neutralising immunity after vaccination.

SARS-CoV-2 mucosal neutralising immunity after vaccination.

Journal: The Lancet. Infectious diseases

Published: August 25, 2023

Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.

Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.

Journal: medRxiv : the preprint server for health sciences

Published: June 09, 2023

Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.

Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.

Journal: The Journal of infection

Published: May 14, 2023

Showing 1-12 of 65

Last Updated: 09/26/2026